Facing billions more in potential settlements, Bayer holds to its legal strategy

Credit: Pixabay/ Mohamed Hassan
Credit: Pixabay/ Mohamed Hassan

Bayer is sticking to its legal strategy of trying individual Roundup cases in court, even as a series of recent losses has some investors and plaintiffs’ lawyers questioning the wisdom of that approach.

After nine victories in a row in trial courts, Bayer has lost four straight cases, the latest a whopping $1.56 billion jury verdict out of state court in Missouri. In that case, three plaintiffs claimed exposure to Bayer’s Roundup [glyphosate] herbicide caused their cancer, and the jury concluded the company failed to adequately warn them of the product’s dangers.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Bayer issued a statement after the $1.56 billion verdict in Missouri, voicing its intention to appeal and addressing the four losses.

“We have strong arguments to get the recent unfounded verdicts overturned and the excessive and unconstitutional damages eliminated or greatly reduced,” the company said.

“They’ve got to play what I call the long game, which is common in mass torts,” [attorney Clay Massey] said. “You have to just continue to pick good cases to try, pick the right cases to settle, and then try one case at a time and continue to make the plaintiffs work for outcomes in these cases.”

“It appears that is what Bayer is doing, and if that is what they’re doing, I think it’s the right strategy,” he said.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.